Suppr超能文献

莱氏无胆甾原体膜中糖脂的免疫特性

Immunological properties of glycolipids from membranes of Acholeplasma laidlawii.

作者信息

Ryan M D, Noker P, Matz L L

出版信息

Infect Immun. 1975 Oct;12(4):799-807. doi: 10.1128/iai.12.4.799-807.1975.

Abstract

Glycolipids, the predominant class of lipids in the membranes of Acholeplasma laidlawii, are the haptenic determinants that react with anti-A. Laidlawii serum to fix complement. The predominant complement-fixing activity of the membrane glycolipids was associated with the monoglucoysyl diglyceride, diglucosyl diglyceride, glycerlphosphoryl diglucosyl diglyceride (GPDD), and an unknown lipid B, which did not react with ninhydrin but release glucose and glycerol and traces of phosphorus upon hydrolysis. The glycolipids monoglucosyl diglyceride and diglucosyl diglyceride or GPDD and unknown lipid B were paired as a result of their cross-reactions with selective antisera prepared with the aid of reconstituted membrane complexes containing membrane lipids. Reconstituted membrane complexes assembled from [14C]monoglucosyl diglyceride and delipidated membrane proteins gave optimal complement fixation titers before saturation of the complexes with the ]14C]monoglucosyl diglyceride. The phosphoglycolipid of the membrane, GPDD, was anticomplementary as a pure lipid, a cholesterol liposome, and a reconstituted membrane complex. This anticomplementary activity, which was caused by 3 mug of pure GPDD, affected both human and guinea pig complement. Although human C1, C4, C3, and C5 were not inhibited by GPDD, C2 was inhibited 10-fold by reconstituted membrane complexes containing 150 mug of GPDD. A role for this phosphoglycolipid is discussed in the hypothetical mechanism of inhibition of C2 attachment to SAC1, 4 sites.

摘要

糖脂是莱氏无胆甾原体膜中主要的脂质类别,是与抗莱氏无胆甾原体血清发生反应以固定补体的半抗原决定簇。膜糖脂的主要补体固定活性与单葡萄糖基甘油二酯、双葡萄糖基甘油二酯、甘油磷酸双葡萄糖基甘油二酯(GPDD)以及一种未知脂质B相关,该未知脂质B与茚三酮不反应,但水解时会释放葡萄糖、甘油和微量磷。单葡萄糖基甘油二酯和双葡萄糖基甘油二酯或GPDD与未知脂质B这两种糖脂,由于它们与借助含有膜脂质的重组膜复合物制备的选择性抗血清发生交叉反应而被配对。由[14C]单葡萄糖基甘油二酯和脱脂膜蛋白组装而成的重组膜复合物,在复合物被[14C]单葡萄糖基甘油二酯饱和之前,能产生最佳的补体固定滴度。膜中的磷酸糖脂GPDD,作为纯脂质、胆固醇脂质体和重组膜复合物时具有抗补体作用。由3微克纯GPDD引起的这种抗补体活性,对人和豚鼠补体均有影响。尽管人C1、C4、C3和C5不受GPDD抑制,但含有150微克GPDD的重组膜复合物可使C2受到10倍的抑制。本文讨论了这种磷酸糖脂在C2附着于SAC1、4位点的抑制假说机制中的作用。

相似文献

引用本文的文献

本文引用的文献

1
Localization of Enzymes in Mycoplasma.支原体中酶的定位
J Bacteriol. 1965 Sep;90(3):617-22. doi: 10.1128/jb.90.3.617-622.1965.
5
OSMOTIC LYSIS OF MYCOPLASMA.支原体的渗透性裂解
J Gen Microbiol. 1963 Dec;33:471-5. doi: 10.1099/00221287-33-3-471.
6
Precise standardization of reagents for complement fixation.补体结合反应试剂的精确标准化
Am J Trop Med Hyg. 1963 Jan;12:103-16. doi: 10.4269/ajtmh.1963.12.103.
7
Immunochemical analysis based on complement fixation.基于补体结合的免疫化学分析。
Ann N Y Acad Sci. 1957 Dec 16;69(4):608-32. doi: 10.1111/j.1749-6632.1957.tb49700.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验